Health Affairs, 28, no. 5 (2009): w957-w968
(Published online 25 August 2009)
doi: 10.1377/hlthaff.28.5.w957
© 2009 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Full Text (HTML)
* Reprint (PDF)
* Appendix
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Google Scholar
* Articles by Shaffer, E. R.
* Articles by Brenner, J. E.
PubMed
* PubMed Citation
* Articles by Shaffer, E. R.
* Articles by Brenner, J. E.
Related Collections
* Access To Care
* Health Promotion/Disease Prevention
* AIDS/HIV
* International Issues
* Legal/Regulatory Issues
* Business Of Health
* Pharmaceuticals
* Public Health
* Research And Technology
* Politics
* Consumer Issues
*Related Articles

Web Exclusives

A Trade Agreement’s Impact On Access To Generic Drugs

Ellen R. Shaffer and Joseph E. Brenner

Millions of people lack access to affordable medicines. The intellectual property rules in the Central America Free Trade Agreement (CAFTA) provide pharmaceutical companies with monopoly protections that allow them to market some drugs without competition by less costly generics. We examined availability of certain drugs in Guatemala and found that CAFTA intellectual property rules reduced access to some generic drugs already on the market and delayed new entry of other generics. Some drugs protected from competition in Guatemala will become open for generic competition in the United States before generic versions will be legally available in Guatemala.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?

Related Articles